Copyright Reports & Markets. All rights reserved.

Global Meloxicam Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Meloxicam Drug

      • 1.1 Definition of Meloxicam Drug
      • 1.2 Meloxicam Drug Segment by Type
        • 1.2.1 Global Meloxicam Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Tablet
        • 1.2.3 Capsule
      • 1.3 Meloxicam Drug Segment by Applications
        • 1.3.1 Global Meloxicam Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Osteoarthritis in adults (OA)
        • 1.3.3 Rheumatoid Arthritis in adults (RA)
        • 1.3.4 Pediatric patients
      • 1.4 Global Meloxicam Drug Overall Market
        • 1.4.1 Global Meloxicam Drug Revenue (2014-2025)
        • 1.4.2 Global Meloxicam Drug Production (2014-2025)
        • 1.4.3 North America Meloxicam Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Meloxicam Drug Status and Prospect (2014-2025)
        • 1.4.5 China Meloxicam Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Meloxicam Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Meloxicam Drug Status and Prospect (2014-2025)
        • 1.4.8 India Meloxicam Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Meloxicam Drug
      • 2.3 Manufacturing Process Analysis of Meloxicam Drug
      • 2.4 Industry Chain Structure of Meloxicam Drug

      3 Development and Manufacturing Plants Analysis of Meloxicam Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Meloxicam Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Meloxicam Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Meloxicam Drug Production and Capacity Analysis
      • 4.2 Meloxicam Drug Revenue Analysis
      • 4.3 Meloxicam Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Meloxicam Drug Regional Market Analysis

      • 5.1 Meloxicam Drug Production by Regions
        • 5.1.1 Global Meloxicam Drug Production by Regions
        • 5.1.2 Global Meloxicam Drug Revenue by Regions
      • 5.2 Meloxicam Drug Consumption by Regions
      • 5.3 North America Meloxicam Drug Market Analysis
        • 5.3.1 North America Meloxicam Drug Production
        • 5.3.2 North America Meloxicam Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Meloxicam Drug Import and Export
      • 5.4 Europe Meloxicam Drug Market Analysis
        • 5.4.1 Europe Meloxicam Drug Production
        • 5.4.2 Europe Meloxicam Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Meloxicam Drug Import and Export
      • 5.5 China Meloxicam Drug Market Analysis
        • 5.5.1 China Meloxicam Drug Production
        • 5.5.2 China Meloxicam Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Meloxicam Drug Import and Export
      • 5.6 Japan Meloxicam Drug Market Analysis
        • 5.6.1 Japan Meloxicam Drug Production
        • 5.6.2 Japan Meloxicam Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Meloxicam Drug Import and Export
      • 5.7 Southeast Asia Meloxicam Drug Market Analysis
        • 5.7.1 Southeast Asia Meloxicam Drug Production
        • 5.7.2 Southeast Asia Meloxicam Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Meloxicam Drug Import and Export
      • 5.8 India Meloxicam Drug Market Analysis
        • 5.8.1 India Meloxicam Drug Production
        • 5.8.2 India Meloxicam Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Meloxicam Drug Import and Export

      6 Meloxicam Drug Segment Market Analysis (by Type)

      • 6.1 Global Meloxicam Drug Production by Type
      • 6.2 Global Meloxicam Drug Revenue by Type
      • 6.3 Meloxicam Drug Price by Type

      7 Meloxicam Drug Segment Market Analysis (by Application)

      • 7.1 Global Meloxicam Drug Consumption by Application
      • 7.2 Global Meloxicam Drug Consumption Market Share by Application (2014-2019)

      8 Meloxicam Drug Major Manufacturers Analysis

      • 8.1 Boehringer-Ingelheim
        • 8.1.1 Boehringer-Ingelheim Meloxicam Drug Production Sites and Area Served
        • 8.1.2 Boehringer-Ingelheim Product Introduction, Application and Specification
        • 8.1.3 Boehringer-Ingelheim Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 TerSera Therapeutics
        • 8.2.1 TerSera Therapeutics Meloxicam Drug Production Sites and Area Served
        • 8.2.2 TerSera Therapeutics Product Introduction, Application and Specification
        • 8.2.3 TerSera Therapeutics Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Iroko Pharmaceuticals
        • 8.3.1 Iroko Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        • 8.3.2 Iroko Pharmaceuticals Product Introduction, Application and Specification
        • 8.3.3 Iroko Pharmaceuticals Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Apotex
        • 8.4.1 Apotex Meloxicam Drug Production Sites and Area Served
        • 8.4.2 Apotex Product Introduction, Application and Specification
        • 8.4.3 Apotex Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Yung Shin Pharmaceutical
        • 8.5.1 Yung Shin Pharmaceutical Meloxicam Drug Production Sites and Area Served
        • 8.5.2 Yung Shin Pharmaceutical Product Introduction, Application and Specification
        • 8.5.3 Yung Shin Pharmaceutical Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Breckenridge Pharmaceutical
        • 8.6.1 Breckenridge Pharmaceutical Meloxicam Drug Production Sites and Area Served
        • 8.6.2 Breckenridge Pharmaceutical Product Introduction, Application and Specification
        • 8.6.3 Breckenridge Pharmaceutical Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Zydus Pharmaceuticals
        • 8.7.1 Zydus Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        • 8.7.2 Zydus Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Zydus Pharmaceuticals Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Unichem Pharmaceuticals
        • 8.8.1 Unichem Pharmaceuticals Meloxicam Drug Production Sites and Area Served
        • 8.8.2 Unichem Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Unichem Pharmaceuticals Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Strides Pharma
        • 8.9.1 Strides Pharma Meloxicam Drug Production Sites and Area Served
        • 8.9.2 Strides Pharma Product Introduction, Application and Specification
        • 8.9.3 Strides Pharma Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Cipla
        • 8.10.1 Cipla Meloxicam Drug Production Sites and Area Served
        • 8.10.2 Cipla Product Introduction, Application and Specification
        • 8.10.3 Cipla Meloxicam Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Dr. Reddy's Laboratories
      • 8.12 Glenmark Pharmaceuticals
      • 8.13 Teva
      • 8.14 PuraCap Pharmaceutical
      • 8.15 TARO
      • 8.16 Lupin Pharmaceuticals
      • 8.17 Aurobindo Pharma

      9 Development Trend of Analysis of Meloxicam Drug Market

      • 9.1 Global Meloxicam Drug Market Trend Analysis
        • 9.1.1 Global Meloxicam Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Meloxicam Drug Regional Market Trend
        • 9.2.1 North America Meloxicam Drug Forecast 2019-2025
        • 9.2.2 Europe Meloxicam Drug Forecast 2019-2025
        • 9.2.3 China Meloxicam Drug Forecast 2019-2025
        • 9.2.4 Japan Meloxicam Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Meloxicam Drug Forecast 2019-2025
        • 9.2.6 India Meloxicam Drug Forecast 2019-2025
      • 9.3 Meloxicam Drug Market Trend (Product Type)
      • 9.4 Meloxicam Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Meloxicam Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 

        The global Meloxicam Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Meloxicam Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Meloxicam Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Meloxicam Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Meloxicam Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Boehringer-Ingelheim
        TerSera Therapeutics
        Iroko Pharmaceuticals
        Apotex
        Yung Shin Pharmaceutical
        Breckenridge Pharmaceutical
        Zydus Pharmaceuticals
        Unichem Pharmaceuticals
        Strides Pharma
        Cipla
        Dr. Reddy's Laboratories
        Glenmark Pharmaceuticals
        Teva
        PuraCap Pharmaceutical
        TARO
        Lupin Pharmaceuticals
        Aurobindo Pharma

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Tablet
        Capsule

        Segment by Application
        Osteoarthritis in adults (OA)
        Rheumatoid Arthritis in adults (RA)
        Pediatric patients

        Buy now